These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

885 related items for PubMed ID: 31880071

  • 1. Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study.
    Qu XL, Zheng B, Chen TY, Cao ZR, Qu B, Jiang T.
    Orthop Surg; 2020 Feb; 12(1):116-123. PubMed ID: 31880071
    [Abstract] [Full Text] [Related]

  • 2. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
    Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W, Ning Z, Huang W, Jiang Y, Li M, Wang O, Xing X, Sun Y, Luo L, He S, Yu W, Lin Q, Pei Y, Zhang F, Han Y, Tong Y, Che Y, Shen R, Hu Y, Zhou X, Xu L.
    Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
    [Abstract] [Full Text] [Related]

  • 3. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
    Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T.
    Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
    [Abstract] [Full Text] [Related]

  • 4. Correlation between bone mineral density and bone metabolic markers in postmenopausal women with osteoporotic fractures at different C-terminal telopeptide of type 1 collagen levels: a retrospective analysis study.
    Zhu X, Chen L, Pan L, Zeng Y, Fu Q, Liu Y, Peng Y, Wang Y, You L.
    Menopause; 2023 Nov 01; 30(11):1139-1146. PubMed ID: 37847873
    [Abstract] [Full Text] [Related]

  • 5. Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures.
    Shigdel R, Osima M, Ahmed LA, Joakimsen RM, Eriksen EF, Zebaze R, Bjørnerem Å.
    Bone; 2015 Dec 01; 81():1-6. PubMed ID: 26112819
    [Abstract] [Full Text] [Related]

  • 6. Analysis of changes in serum high t-PINP/β-CTX ratio and risk of re-fracture after vertebral osteoporotic fracture surgery.
    Lin XB, Ye H, He LJ, Xu ZB.
    Eur Rev Med Pharmacol Sci; 2023 Nov 01; 27(22):10860-10867. PubMed ID: 38039015
    [Abstract] [Full Text] [Related]

  • 7. Oxytocin and bone status in men: analysis of the MINOS cohort.
    Breuil V, Fontas E, Chapurlat R, Panaia-Ferrari P, Yahia HB, Faure S, Euller-Ziegler L, Amri EZ, Szulc P.
    Osteoporos Int; 2015 Dec 01; 26(12):2877-82. PubMed ID: 26109496
    [Abstract] [Full Text] [Related]

  • 8. [Relationship of iron overload to bone mass density and bone turnover in postmenopausal women with fragility fractures of the hip].
    Zhang LL, Jiang XF, Ai HZ, Jin ZD, Xu JX, Wang B, Xu W, Xie ZG, Zhou HB, Dong QR, Xu YJ.
    Zhonghua Wai Ke Za Zhi; 2013 Jun 01; 51(6):518-21. PubMed ID: 24091266
    [Abstract] [Full Text] [Related]

  • 9. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial.
    Bauer DC, Garnero P, Hochberg MC, Santora A, Delmas P, Ewing SK, Black DM, Fracture Intervention Research Group.
    J Bone Miner Res; 2006 Feb 01; 21(2):292-9. PubMed ID: 16418785
    [Abstract] [Full Text] [Related]

  • 10. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.
    Cortet B, Cortet C, Blanckaert F, d'Herbomez M, Marchandise X, Wémeau J-L, Decoulx M, Dewailly D.
    Osteoporos Int; 2001 Feb 01; 12(2):117-23. PubMed ID: 11303711
    [Abstract] [Full Text] [Related]

  • 11. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y, Haifa H, Datel O, Fadoua HN, Smeh BH, Mahbouba J, Saoussen Z, Bejia I, Mongi T, Mohamed FN, Naceur B.
    Tunis Med; 2014 May 01; 92(5):304-10. PubMed ID: 25504382
    [Abstract] [Full Text] [Related]

  • 12. Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Tamaki J, Iki M, Kadowaki E, Sato Y, Chiba Y, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagawa Y, Yoneshima H, JPOS Study Group.
    Osteoporos Int; 2013 Mar 01; 24(3):887-97. PubMed ID: 22885773
    [Abstract] [Full Text] [Related]

  • 13. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F, Eriksen EF, Recknor C, Miller PD, Guañabens N, Kasperk C, Papanastasiou P, Readie A, Rao H, Gasser JA, Bucci-Rechtweg C, Boonen S.
    J Bone Miner Res; 2011 Mar 01; 26(3):503-11. PubMed ID: 20814967
    [Abstract] [Full Text] [Related]

  • 14. [Clinical value of serum total P1NP, β-CTX and 25(OH)D3 detection in evaluating risks of fragile hip fracture in elderly patients with osteoporosis].
    Lou H, Peng C, Chen Q.
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep 01; 32(9):1346-9. PubMed ID: 22985580
    [Abstract] [Full Text] [Related]

  • 15. [Correlation between serum HDL/LDL and t-PINP /β-CTX and osteoporotic vertebral fractures in elderly women].
    Sang Y, Zou M, Yue JB.
    Zhongguo Gu Shang; 2024 Jun 25; 37(6):5655-70. PubMed ID: 38910378
    [Abstract] [Full Text] [Related]

  • 16. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
    Nguyen LT, Nguyen UDT, Nguyen TDT, Ho-Pham LT, Nguyen TV.
    Osteoporos Int; 2018 Dec 25; 29(12):2739-2744. PubMed ID: 30196375
    [Abstract] [Full Text] [Related]

  • 17. Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women.
    Bruyere O, Collette J, Delmas P, Rouillon A, Roux C, Seidel L, Richy F, Reginster JY.
    Maturitas; 2003 Apr 25; 44(4):259-65. PubMed ID: 12697366
    [Abstract] [Full Text] [Related]

  • 18.
    Williams C, Sapra A.
    ; 2024 01 25. PubMed ID: 32644732
    [Abstract] [Full Text] [Related]

  • 19. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.
    Jiajue R, Jiang Y, Wang O, Li M, Xing X, Cui L, Yin J, Xu L, Xia W.
    Osteoporos Int; 2014 Aug 25; 25(8):1999-2005. PubMed ID: 24760246
    [Abstract] [Full Text] [Related]

  • 20. Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
    Bønløkke SE, Rand MS, Haddock B, Arup S, Smith CD, Jensen JEB, Schwarz P, Hovind P, Oturai PS, Jensen LT, Møller S, Eiken P, Rubin KH, Hitz MF, Abrahamsen B, Jørgensen NR.
    Osteoporos Int; 2022 Oct 25; 33(10):2155-2164. PubMed ID: 35729342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.